In the New England Journal of Medicine, scientists report that a new experimental drug called ibrutinib significantly prolongs the life of chronic lymphocytic leukemia (CLL) with fewer side effects than chemotherapy. To learn more, click here…..
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Leave a Reply